Refined genotype-phenotype correlations in neurofibromatosis type 1 patients with NF1 point variants

  • Laurence Pacot
  • , Marinus Blok
  • , Dominique Vidaud
  • , Laura Fertitta
  • , Ingrid Laurendeau
  • , Audrey Coustier
  • , Theodora Maillard
  • , Cécile Barbance
  • , Djihad Hadjadj
  • , Manuela Ye
  • , Dominique Lallemand
  • , Salah Ferkal
  • , Benoit Funalot
  • , Ariane Lunati-Rozie
  • , Bérénice Hebrard
  • , Rakia Bhouri
  • , Liesbeth Spruijt
  • , Didier Bessis
  • , David Geneviève
  • , Vivian Vernimmen
  • Martinus P G Broen, Sabine Sigaudy, Sylvie Odent, Léna Damaj, Chloé Quélin, Laurent Pasquier, Valérie Layet, Brigitte Gilbert-Dussardier, Gaël Nicolas, Anne-Marie Guerrot, Bruno Leheup, Anne-Claire Bursztejn, Florence Petit, Odile Boute-Bénéjean, Yline Capri, Anne Guimier, Stanislas Lyonnet, Genevieve Baujat, Emmanuelle Bourrat, Bertrand Isidor, Mathilde Nizon, Sébastien Barbarot, Annick Toutain, Sophie Blesson, Julien Van-Gils, Fanny Morice-Picard, Séverine Audebert-Bellanger, Juliette Mazereeuw-Hautier, Alban Ziegler, Yves Alembik, NF-France network

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background Neurofibromatosis type 1 (NF1) is one of the most frequent genetic disorders. NF1 is caused by dominant loss-of-function pathogenic variants (PVs) of the tumour-suppressor gene NF1, which encodes neurofibromin, a negative regulator of rat sarcoma proteins. NF1 is an autosomal dominant disorder with complete penetrance, but a highly variable expression. Identification of genotype–phenotype correlations is challenging because of the wide clinical variability, the progressive nature of the disorder and the extreme diversity of the mutation spectrum. Only a few NF1 point variants have been associated with a specific phenotype in NF1 patients. Methods We investigated a large, well-phenotyped NF1 cohort. Results We report analyses of genotype-phenotype correlations in 112 NF1 patients with specific NF1 point variants: p.Arg1809 missense variants were associated with a mild form of NF1 (n=24), while a more severe phenotype was associated with codons 844–848 (n=27), p.Arg1276 (n=25) and p.Lys1423 (n=35) missense variants. We describe a new correlation for p.Arg1204 missense variants (n=11), with no neurofibroma observed in patients. Functional studies will be critical for drawing conclusions on the potential hypomorphic or dominant-negative effects of these variants. Conclusion The current data confirms several genotype-phenotype correlations in NF1, which may be relevant to the management and surveillance of NF1 patients with specific NF1 PVs.

Original languageEnglish
Pages (from-to)783-793
Number of pages11
JournalJournal of Medical Genetics
Volume62
Issue number12
Early online date4 Aug 2025
DOIs
Publication statusPublished - 1 Dec 2025

Keywords

  • Genetic Diseases, Inborn

Fingerprint

Dive into the research topics of 'Refined genotype-phenotype correlations in neurofibromatosis type 1 patients with NF1 point variants'. Together they form a unique fingerprint.

Cite this